Evidence map›Paper›PMID 20676378›Full record

ArticlePloS one2010

Unlocking short read sequencing for metagenomics.

Sébastien Rodrigue, Arne C Materna, Sonia C Timberlake, Matthew C Blackburn, Rex R Malmstrom, Eric J Alm, Sallie W Chisholm

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 86 papers.

0numbers the graph read from it
0cells of the map it votes in
86citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

86 citing papers in PubMed, 168 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of arsenic oxidizing genes fragment inSaudi journal of biological sciences · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. RNA Sequencing for Transcript 5'-End Mapping in Mycobacteria.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  8. Review
  9. The development of colitis in Il10Mucosal immunology · 2020
    Article
  10. Article
  11. Article
  12. Article
  13. The DNA double-strand "breakome" of mouse spermatids.Cellular and molecular life sciences : CMLS · 2018
    Article
  14. Article
  15. Article
  16. Development ofApplied and environmental microbiology · 2017
    Article
  17. Article
  18. Article
  19. Mutational landscape of EGFR-, MYC-, and Kras-driven genetically engineered mouse models of lung adenocarcinoma.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  20. Article

26 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sébastien RodrigueDepartment of Civil and Environmental Engineering, Massachusetts Institute of Technology, Cambridge, Massachussetts, United States of America.
Arne C Materna
Sonia C Timberlake
Matthew C Blackburn
Rex R Malmstrom
Eric J Alm
Sallie W Chisholm
Massachusetts Institute of Technology · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDifferent high-throughput nucleic acid sequencing platforms are currently available but a trade-off currently exists between the cost and number of reads that can be generated versus the read length that can be achieved. METHODOLOGY/PRINCIPAL

findingsWe describe an experimental and computational pipeline yielding millions of reads that can exceed 200 bp with quality scores approaching that of traditional Sanger sequencing. The method combines an automatable gel-less library construction step with paired-end sequencing on a short-read instrument. With appropriately sized library inserts, mate-pair sequences can overlap, and we describe the SHERA software package that joins them to form a longer composite read. CONCLUSIONS/SIGNIFICANCE: This strategy is broadly applicable to sequencing applications that benefit from low-cost high-throughput sequencing, but require longer read lengths. We demonstrate that our approach enables metagenomic analyses using the Illumina Genome Analyzer, with low error rates, and at a fraction of the cost of pyrosequencing.

Indexed as

MetagenomicsSequence Analysis, DNASoftware

Identifiers

PMID20676378
PMCPMC2911387
OpenAlexW2151671981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.